News

Individuals with alcohol use disorders are twice as likely as those without a history of problem drinking to suffer from memory loss in the future.

Researchers debunked the long-standing premise that there is a strong association between mental illness and crime by determining substance addiction is a stronger predictor of recidivism among offenders.

The term pre-diabetes has limited clinical value as a majority of patients who fall into the category do not go on to develop type 2 diabetes, according to researchers.

An additional biomarker may predict future epilepsy development in febrile seizure sufferers, according to researchers at the University of California, Irvine.

New research disputes a widely publicized study that linked testosterone replacement therapy with an increased risk of cardiovascular events and all-cause mortality.

Treatment-resistant cases of trigeminal neuralgia may be treated with duloxetine, according to a new case study.

Researchers at Auburn University are joining what is becoming a crowded field of teams looking to develop a drug to treat future outbreaks of the Ebola virus.

Orbactiv (oritavancin) is a new antibacterial drug approved to treat patients with acute bacterial skin and skin structure infections.

Patients with painful diabetic polyneuropathy can have higher nocturnal blood pressure, according to a study published in Diabetes Care.

Now that the two American patients infected with Ebola have arrived safely in Atlanta, the US Centers for Disease Control and Prevention has released more information about ZMapp, the experimental medication the patients were treated with before being flown back to the US.

While scientists have previously identified the changes to brain tissue and organs caused by alcoholism, a team of researchers has now shown the long-term neurological effects of excessive drinking on a molecular level.

By observing mutated flies, researchers at the University of Iowa found the same pathophysiological pathways are relevant to epilepsy and several neurodegenerative disorders.

Dust mites are widely responsible for allergic irritation and breathing difficulties, but researchers from the University of Iowa researchers indicated a vaccine may be within reach.

Immune cells responsible for intestinal movement may be the key to an effective treatment for irritable bowel syndrome.

Sex addicts and drug addicts display similar brain activity when they are triggered with the appropriate stimuli.

Recent discoveries indicate there is an "autoimmune contribution" to the source of chronic pain for Complex Regional Pain Syndrome sufferers.

Often physicians compare the condition of obese and overweight children to their parents and siblings as an explanation for their weight.

A team of researchers has pinpointed a small molecule responsible for nerve cell damage and other symptoms tied to neurological diseases, including multiple sclerosis (MS).

After looking at a national sampling of high school seniors, researchers at New York University determined the strongest predictor of ecstasy use was prior drug consumption.

Researchers examine whether patients with hypertension, diabetes, and hyperlipidemia saw improved health outcomes after Massachusetts Health Reform was implemented in 2006.

Ebola virus symptoms often mimic those associated with other infectious diseases, making diagnosis a complex process. Treatment consists mainly of supportive care.

As life expectancies for cystic fibrosis patients have increased, so have possible long-term complications such as diabetes.

As nearly half of the baby boomer generation joins the group of people with erectile dysfunction, patients with the condition are becoming more vocal about living with the condition and their desire to overcome it.

Increased activity in the prefrontal cortex and nucleus accumbens explained why bipolar disorder patients took larger gambling risks.

The University of Southern California is developing a brain model that can pave the way for nanotechnology treatment development for multiple sclerosis and other neurological disorders.

Despite these improvements in medical technology, diabetic nephropathy remains unpredictable and life-threatening. Identifying high-risk patients at an early stage could help clinicians take appropriate steps to reduce risk.

The US Food and Drug Administration announced the approval of Jardiance (empagliflozin) to treat adults with type 2 diabetes.

Two recent studies have identified gene variants and mutations that significantly increased the likelihood of schizophrenia, alcoholism, and bipolar disorder development.

Even a "magic bullet" leaves a wound that requires a period of recovery.

The US Food and Drug Administration announced the approval of a new drug for the treatment of chronic obstructive pulmonary disease.